{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:33:55Z","timestamp":1792679635519,"version":"4.5.0"},"reference-count":149,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","redjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ijrobp.2023.11.050","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T17:20:39Z","timestamp":1701364839000},"page":"42-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Radiation Therapy and Myeloid-Derived Suppressor Cells: Breaking Down Their Cancerous Partnership"],"prefix":"10.1016","volume":"119","author":[{"given":"Kyra M. Boorsma","family":"Bergerud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Berkseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew M.","family":"Pardoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudipto","family":"Ganguly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence R.","family":"Kleinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Odde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Largaespada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Terezakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1904-8376","authenticated-orcid":false,"given":"Lindsey","family":"Sloan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2023.11.050_bib0001","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fmolb.2014.00024","article-title":"Biological response of cancer cells to radiation treatment","volume":"1","author":"Baskar","year":"2014","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0002","doi-asserted-by":"crossref","first-page":"e557s","DOI":"10.6061\/clinics\/2018\/e557s","article-title":"Radiotherapy and immune response: The systemic effects of a local treatment","volume":"73","author":"de Andrade Carvalho","year":"2018","journal-title":"Clinics"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0003","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1593\/neo.11024","article-title":"B cells are critical to T-cell\u2013mediated antitumor immunity induced by a combined immune-stimulatory\/conditionally cytotoxic therapy for glioblastoma","volume":"13","author":"Candolfi","year":"2011","journal-title":"Neoplasia"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0004","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.6004\/jnccn.2015.0151","article-title":"Survival in patients with severe lymphopenia following treatment with radiation and chemotherapy for newly diagnosed solid tumors","volume":"13","author":"Grossman","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0005","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3233\/CBM-210292","article-title":"Early onset of severe lymphopenia during definitive radiotherapy correlates with mean body dose and predicts poor survival in cervical cancer","volume":"34","author":"Yang","year":"2022","journal-title":"CBM"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0006","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/07357907.2013.767342","article-title":"Treatment-related lymphopenia in patients with stage III non-small-cell lung cancer","volume":"31","author":"Campian","year":"2013","journal-title":"Cancer Invest"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0007","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s10147-020-01623-y","article-title":"Postradiotherapy persistent lymphopenia as a poor prognostic factor in patients with cervical cancer receiving radiotherapy: A single-center, retrospective study","volume":"25","author":"Taguchi","year":"2020","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0008","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13014-020-01494-7","article-title":"Radiation-induced lymphopenia correlates with survival in nasopharyngeal carcinoma: Impact of treatment modality and the baseline lymphocyte count","volume":"15","author":"Xie","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0009","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.21037\/tlcr-20-831","article-title":"Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio associations with heart and body dose and their effects on patient outcomes in locally advanced non-small cell lung cancer treated with definitive radiotherapy","volume":"9","author":"Xia","year":"2020","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0010","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.ijrobp.2004.12.085","article-title":"Primary brain tumors treated with steroids and radiotherapy: Low CD4 counts and risk of infection","volume":"62","author":"Hughes","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0011","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2307\/3577549","article-title":"Radiosensitivity of CD4 or CD8 positive human T-lymphocytes by an in vitro colony formation assay","volume":"123","author":"Nakamura","year":"1990","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0012","doi-asserted-by":"crossref","first-page":"962","DOI":"10.4143\/crt.2020.1053","article-title":"Role of interleukin-7 in the development of and recovery from radiation-induced lymphopenia: A post-hoc analysis of a prospective cohort","volume":"53","author":"Byun","year":"2021","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0013","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3389\/fimmu.2017.00828","article-title":"Reprogramming of tumor-associated macrophages with anticancer therapies: Radiotherapy versus chemo- and immunotherapies","volume":"8","author":"Genard","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583084","article-title":"Tumor-associated macrophages in tumor immunity","volume":"11","author":"Pan","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0015","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1596004","article-title":"Interaction of tumor-associated macrophages and cancer chemotherapy","volume":"8","author":"Larionova","year":"2019","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0016","doi-asserted-by":"crossref","first-page":"e50946","DOI":"10.1371\/journal.pone.0050946","article-title":"Prognostic significance of tumor-associated macrophages in solid tumor: A meta-analysis of the literature","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0017","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nrc3958","article-title":"The tumour microenvironment after radiotherapy: Mechanisms of resistance and recurrence","volume":"15","author":"Barker","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0018","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/cei.12344","article-title":"Low and moderate doses of ionizing radiation up to 2 Gy modulate transmigration and chemotaxis of activated macrophages, provoke an anti-inflammatory cytokine milieu, but do not impact upon viability and phagocytic function","volume":"179","author":"Wunderlich","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0019","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1158\/1078-0432.CCR-08-1471","article-title":"Radiotherapy decreases vascular density and causes hypoxia with macrophage aggregation in TRAMP-C1 prostate tumors","volume":"15","author":"Chen","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0020","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.21873\/invivo.11668","article-title":"Ionizing radiation promotes epithelial\u2013to\u2013mesenchymal transition in lung epithelial cells by TGF-\u03b2-producing M2 macrophages","volume":"33","author":"Park","year":"2019","journal-title":"In Vivo"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0021","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.tips.2018.10.008","article-title":"MDSC; the most important cell you have never heard of","volume":"40","author":"Tesi","year":"2019","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0022","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1186\/s12885-018-5086-y","article-title":"Prognostic role of myeloid-derived suppressor cells in cancers: A systematic review and meta-analysis","volume":"18","author":"Ai","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0023","doi-asserted-by":"crossref","first-page":"E650","DOI":"10.1016\/j.ijrobp.2019.06.1029","article-title":"The immunodynamics of myeloid-derived suppressor cell and monocyte populations in the peripheral blood in patients with newly diagnosed glioblastoma undergoing adjuvant temozolomide and radiation therapy","volume":"105","author":"Sloan","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0024","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3389\/fimmu.2020.01191","article-title":"Glioblastoma myeloid-derived suppressor cell subsets express differential macrophage migration inhibitory factor receptor profiles that can be targeted to reduce immune suppression","volume":"11","author":"Alban","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0025","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3389\/fonc.2019.00215","article-title":"Radiotherapy both promotes and inhibits myeloid-derived suppressor cell function: Novel strategies for preventing the tumor-protective effects of radiotherapy","volume":"9","author":"Ostrand-Rosenberg","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0026","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.radonc.2016.01.014","article-title":"Myeloid-derived suppressor cells reveal radioprotective properties through arginase-induced l-arginine depletion","volume":"119","author":"Leonard","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0027","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000368233","article-title":"Myeloid-Derived suppressor cells: Paradoxical roles in infection and immunity","volume":"7","author":"Dai","year":"2015","journal-title":"J Innate Immun"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0028","doi-asserted-by":"crossref","unstructured":"Brandau S, Dorhoi A, eds. Myeloid-Derived Suppressor Cells. Vol. 2236. New York, NY: Humana New York, 2020.","DOI":"10.1007\/978-1-0716-1060-2"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0029","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"STATs in cancer inflammation and immunity: A leading role for STAT3","volume":"9","author":"Yu","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0030","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0031","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2220\/biomedres.30.7","article-title":"Potential differentiation of tumor bearing mouse CD11b+Gr-1+ immature myeloid cells into both suppressor macrophages and immunostimulatory dendritic cells","volume":"30","author":"Narita","year":"2009","journal-title":"Biomed Res"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0032","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00262-008-0523-4","article-title":"Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin\u2013cyclophosphamide chemotherapy","volume":"58","author":"Diaz-Montero","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0033","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1479-5876-9-90","article-title":"Functional characterization of human Cd33+ And Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines","volume":"9","author":"Lechner","year":"2011","journal-title":"J Transl Med"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0034","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1189\/jlb.0311177","article-title":"Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice","volume":"91","author":"Youn","year":"2012","journal-title":"J Leukoc Biol."},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0035","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.741305","article-title":"Tumor-associated macrophages and their functional transformation in the hypoxic tumor microenvironment","volume":"12","author":"He","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.938289","article-title":"Roles of tumor-associated neutrophils in tumor metastasis and its clinical applications","volume":"10","author":"Yan","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0038","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2021.04.004","article-title":"MDSC: Markers, development, states, and unaddressed complexity","volume":"54","author":"Hegde","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0039","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0040","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ccell.2015.07.006","article-title":"RORC1 regulates tumor-promoting \u201cemergency\u201d granulo-monocytopoiesis","volume":"28","author":"Strauss","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0041","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202000893","article-title":"Human G-MDSCs are neutrophils at distinct maturation stages promoting tumor growth in breast cancer","volume":"3","author":"Mehmeti-Ajradini","year":"2020","journal-title":"Life Sci Alliance"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0042","doi-asserted-by":"crossref","first-page":"aaf8943","DOI":"10.1126\/sciimmunol.aaf8943","article-title":"Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients","volume":"1","author":"Condamine","year":"2016","journal-title":"Sci Immunol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0043","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1158\/0008-5472.CAN-08-1921","article-title":"Arginase I\u2013producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes","volume":"69","author":"Rodriguez","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0044","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1118\/1.2816228","article-title":"Hypofractionation in radiation therapy and its impact: Radiation therapy hypofractionation","volume":"35","author":"Papiez","year":"2007","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0045","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13014-019-1382-1","article-title":"Stereotactic ablative radiotherapy versus conventionally fractionated radiotherapy in the treatment of hepatocellular carcinoma with portal vein invasion: A retrospective analysis","volume":"14","author":"Yang","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0046","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.3390\/ijms22042091","article-title":"Ablative radiotherapy reprograms the tumor microenvironment of a pancreatic tumor in favoring the immune checkpoint blockade therapy","volume":"22","author":"Lee","year":"2021","journal-title":"IJMS"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0047","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1158\/1078-0432.CCR-14-2824","article-title":"Ablative tumor radiation can change the tumor immune cell microenvironment to induce durable complete remissions","volume":"21","author":"Filatenkov","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0048","first-page":"1","article-title":"Myeloid-derived suppressor cells and CD68+CD163+M2-like macrophages as therapeutic response biomarkers are associated with plasma inflammatory cytokines: A preliminary study for non-small cell lung cancer patients in radiotherapy","volume":"2022","author":"Lv","year":"2022","journal-title":"J Immunol Res"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0049","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/bjc.2016.166","article-title":"Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer","volume":"115","author":"Sridharan","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0050","doi-asserted-by":"crossref","first-page":"11279","DOI":"10.18632\/oncotarget.24397","article-title":"Combined modality radiation therapy promotes tolerogenic myeloid cell populations and STAT3-related gene expression in head and neck cancer patients","volume":"9","author":"Sampath","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0051","doi-asserted-by":"crossref","first-page":"7205","DOI":"10.1158\/0008-5472.CAN-14-1913","article-title":"Chemoradiotherapy-induced upregulation of PD-1 antagonizes immunity to HPV-related oropharyngeal cancer","volume":"74","author":"Parikh","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0052","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12865-021-00429-5","article-title":"Cisplatin-based chemoradiation decreases telomerase-specific CD4 TH1 response but increases immune suppressive cells in peripheral blood","volume":"22","author":"Boustani","year":"2021","journal-title":"BMC Immunol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0053","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1267095","article-title":"Impact of (chemo)radiotherapy on immune cell composition and function in cervical cancer patients","volume":"6","author":"van Meir","year":"2017","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0054","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1255393","article-title":"Standard radiotherapy but not chemotherapy impairs systemic immunity in non-small cell lung cancer","volume":"5","author":"Talebian Yazdi","year":"2016","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0055","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.trsl.2015.06.019","article-title":"Tumor-infiltrating lymphocytes, forkhead box P3, programmed death ligand-1, and cytotoxic T lymphocyte\u2013associated antigen-4 expressions before and after neoadjuvant chemoradiation in rectal cancer","volume":"166","author":"Teng","year":"2015","journal-title":"Transl Res"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0056","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/jrr\/rraa083","article-title":"Changes in peripheral immune cells after intraoperative radiation therapy in low-risk breast cancer","volume":"62","author":"Linares-Galiana","year":"2021","journal-title":"J Radiat Res"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0057","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/neuonc\/noq204","article-title":"Immune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiforme","volume":"13","author":"Fadul","year":"2011","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0058","doi-asserted-by":"crossref","first-page":"8261","DOI":"10.18632\/oncotarget.3014","article-title":"Peripheral myeloid-derived suppressor and T regulatory PD-1 positive cells predict response to neoadjuvant short-course radiotherapy in rectal cancer patients","volume":"6","author":"Napolitano","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0059","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.3390\/ijms19123963","article-title":"Preliminary study of the effect of stereotactic body radiotherapy (SBRT) on the immune system in lung cancer patients unfit for surgery: Immunophenotyping analysis","volume":"19","author":"Navarro-Mart\u00edn","year":"2018","journal-title":"IJMS"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0060","doi-asserted-by":"crossref","first-page":"10427","DOI":"10.1007\/s13277-016-4916-2","article-title":"The clinical and prognostic significance of CD14+HLA-DR\u2212\/low myeloid-derived suppressor cells in hepatocellular carcinoma patients receiving radiotherapy","volume":"37","author":"Wang","year":"2016","journal-title":"Tumor Biol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0061","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1245\/s10434-018-6944-1","article-title":"The predictive value of pretreatment neutrophil-to-lymphocyte ratio in esophageal squamous cell carcinoma","volume":"26","author":"Chen","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0062","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2147\/OTT.S124915","article-title":"The lymphocyte-monocyte ratio predicts tumor response and survival in patients with locally advanced esophageal cancer who received definitive chemoradiotherapy","volume":"10","author":"Liu","year":"2017","journal-title":"OTT"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0063","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1038\/onc.2008.271","article-title":"The tumor microenvironment and its role in promoting tumor growth","volume":"27","author":"Whiteside","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0064","doi-asserted-by":"crossref","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The tumor microenvironment","volume":"30","author":"Anderson","year":"2020","journal-title":"Curr Biol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0065","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.3390\/ijms20133212","article-title":"Tumor microenvironment as a \u201cgame changer\u201d in cancer radiotherapy","volume":"20","author":"Jarosz-Biej","year":"2019","journal-title":"IJMS"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0066","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13014-022-02038-x","article-title":"The roles of CC chemokines in response to radiation","volume":"17","author":"Wang","year":"2022","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0067","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1189\/jlb.0708446","article-title":"Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through toll-like receptor 4","volume":"85","author":"Bunt","year":"2009","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0068","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.3390\/cancers14051236","article-title":"Coordinated regulation of myeloid-derived suppressor cells by cytokines and chemokines","volume":"14","author":"Li","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0069","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10138","article-title":"CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis","volume":"475","author":"Qian","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0070","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s00262-017-1988-9","article-title":"CCR5 in recruitment and activation of myeloid-derived suppressor cells in melanoma","volume":"66","author":"Umansky","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0071","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.canlet.2006.12.012","article-title":"CCL2\/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers","volume":"252","author":"Huang","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0072","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","article-title":"The cGAS\u2013STING pathway as a therapeutic target in inflammatory diseases","volume":"21","author":"Decout","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0073","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13045-020-00916-z","article-title":"cGAS-STING, an important pathway in cancer immunotherapy","volume":"13","author":"Jiang","year":"2020","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0074","doi-asserted-by":"crossref","first-page":"7243","DOI":"10.1038\/s41598-021-86644-x","article-title":"cGAS\u2013STING cytosolic DNA sensing pathway is suppressed by JAK2-STAT3 in tumor cells","volume":"11","author":"Suter","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0075","doi-asserted-by":"crossref","first-page":"15408","DOI":"10.1073\/pnas.1512832112","article-title":"STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity","volume":"112","author":"Demaria","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0076","doi-asserted-by":"crossref","first-page":"8877","DOI":"10.3390\/ijms21228877","article-title":"The impact of radiation-induced DNA damage on cGAS-STING-mediated immune responses to cancer","volume":"21","author":"Storozynsky","year":"2020","journal-title":"IJMS"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0077","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1158\/0008-5472.CAN-10-2820","article-title":"The efficacy of radiotherapy relies upon induction of type I interferon\u2013dependent innate and adaptive immunity","volume":"71","author":"Burnette","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0078","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00262-013-1506-7","article-title":"Type I interferons induced by radiation therapy mediate recruitment and effector function of CD8+ T cells","volume":"63","author":"Lim","year":"2014","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0079","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/s41467-017-01566-5","article-title":"Host STING-dependent MDSC mobilization drives extrinsic radiation resistance","volume":"8","author":"Liang","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0080","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/jcbfm.2014.120","article-title":"Role of CCR2 in inflammatory conditions of the central nervous system","volume":"34","author":"Chu","year":"2014","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0081","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.cell.2017.09.039","article-title":"The DNA inflammasome in human myeloid cells is initiated by a STING-cell death program upstream of NLRP3","volume":"171","author":"Gaidt","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0082","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","article-title":"NLRP3 inflammasome activation and cell death","volume":"18","author":"Huang","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0083","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0084","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1038\/s41467-021-22033-2","article-title":"Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway","volume":"12","author":"Alicea-Torres","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0085","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.chom.2008.11.008","article-title":"Virus-induced unfolded protein response attenuates antiviral defenses via phosphorylation-dependent degradation of the type I interferon receptor","volume":"5","author":"Liu","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0086","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.immuni.2020.03.004","article-title":"The unfolded protein response mediator perk governs myeloid cell-driven immunosuppression in tumors through inhibition of STING signaling","volume":"52","author":"Mohamed","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0087","doi-asserted-by":"crossref","first-page":"22069","DOI":"10.1074\/jbc.M111.238766","article-title":"Role of p38 protein kinase in the ligand-independent ubiquitination and down-regulation of the IFNAR1 chain of type I interferon receptor","volume":"286","author":"Bhattacharya","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0088","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1091\/mbc.e11-06-0510","article-title":"The eIF2 kinase PERK and the integrated stress response facilitate activation of ATF6 during endoplasmic reticulum stress","volume":"22","author":"Teske","year":"2011","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0089","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1038\/s41467-018-05861-7","article-title":"Nrf2 negatively regulates STING indicating a link between antiviral sensing and metabolic reprogramming","volume":"9","author":"Olagnier","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0090","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1535-6108(04)00115-1","article-title":"Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors","volume":"5","author":"Moeller","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0091","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/hep.28655","article-title":"Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26","volume":"64","author":"Chiu","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0092","first-page":"7","article-title":"The role of hypoxia in shaping the recruitment of proangiogenic and immunosuppressive cells in the tumor microenvironment","volume":"22","author":"Chouaib","year":"2018","journal-title":"Contemp Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0093","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.2147\/IJN.S140462","article-title":"Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment","volume":"13","author":"Graham","year":"2018","journal-title":"IJN"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0094","series-title":"Methods in Enzymology. Vol. 381","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0076-6879(04)81023-1","article-title":"Tumor hypoxia and malignant progression","author":"Vaupel","year":"2004"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0095","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0096","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41467-017-00530-7","article-title":"Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2\/CD39L1 in hepatocellular carcinoma","volume":"8","author":"Chiu","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0097","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s12032-019-1329-2","article-title":"The role of vascular endothelial growth factor in the hypoxic and immunosuppressive tumor microenvironment: Perspectives for therapeutic implications","volume":"37","author":"Tamura","year":"2020","journal-title":"Med Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0098","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ccr.2008.01.034","article-title":"HIF1\u03b1 induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion","volume":"13","author":"Du","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0099","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2741\/3674","article-title":"Angiogenic signaling aberrantly induced by tumor hypoxia","volume":"16","author":"Takenaga","year":"2011","journal-title":"Front Biosci"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1748-717X-7-25","article-title":"Post-radiation increase in VEGF enhances glioma cell motility in vitro","volume":"7","author":"Kil","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0101","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1038\/sj.onc.1204258","article-title":"Ionizing radiation modulates vascular endothelial growth factor (VEGF) expression through multiple mitogen activated protein kinase dependent pathways","volume":"20","author":"Park","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0102","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jtho.2016.04.026","article-title":"Effect of first-line treatment on myeloid-derived suppressor cells\u2019 subpopulations in the peripheral blood of patients with non\u2013small cell lung cancer","volume":"11","author":"Koinis","year":"2016","journal-title":"J Thorac Oncology"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0103","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1158\/1078-0432.CCR-16-0387","article-title":"Expression of vascular endothelial growth factor in ovarian cancer inhibits tumor immunity through the accumulation of myeloid-derived suppressor cells","volume":"23","author":"Horikawa","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0104","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4048\/jbc.2011.14.2.88","article-title":"Overexpression of MMP-9 and HIF-1\u03b1 in breast cancer cells under hypoxic conditions","volume":"14","author":"Choi","year":"2011","journal-title":"J Breast Cancer"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0105","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0092-8674(02)00754-7","article-title":"Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand","volume":"109","author":"Heissig","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0106","first-page":"421","article-title":"Expression of matrix metalloproteinases 1, 2, 9 and their tissue inhibitors in stage II non-small cell lung cancer: Implications for MMP inhibition therapy","volume":"8","author":"Pritchard","year":"2001","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0107","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/mc.22767","article-title":"Inhibition of JAK2\/STAT3 reduces tumor-induced angiogenesis and myeloid-derived suppressor cells in head and neck cancer","volume":"57","author":"Liu","year":"2018","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0108","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.4049\/jimmunol.0800854","article-title":"The cooperative induction of hypoxia-inducible factor-1\u03b1 and STAT3 during hypoxia induced an impairment of tumor susceptibility to CTL-mediated cell lysis","volume":"182","author":"Noman","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0109","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1084\/jem.20100587","article-title":"HIF-1\u03b1 regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment","volume":"207","author":"Corzo","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0110","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1158\/0008-5472.CAN-15-0405","article-title":"Tumor-promoting effects of myeloid-derived suppressor cells are potentiated by hypoxia-induced expression of miR-210","volume":"75","author":"Noman","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0111","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/ijc.28449","article-title":"Enhanced suppressive capacity of tumor-infiltrating myeloid-derived suppressor cells compared with their peripheral counterparts","volume":"134","author":"Maenhout","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0112","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1158\/0008-5472.CAN-04-0465","article-title":"Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses","volume":"64","author":"Rodriguez","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0113","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cellimm.2005.01.004","article-title":"L-arginine modulates CD3\u03b6 expression and T cell function in activated human T lymphocytes","volume":"232","author":"Zea","year":"2004","journal-title":"Cell Immunol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0114","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3109\/08820139.2012.680634","article-title":"Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: Mechanisms of T cell suppression and therapeutic perspectives","volume":"41","author":"Raber","year":"2012","journal-title":"Immunol Invest"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0115","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.3389\/fimmu.2018.02499","article-title":"Reactive oxygen species as regulators of MDSC-mediated immune suppression","volume":"9","author":"Ohl","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0116","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nm1609","article-title":"Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer","volume":"13","author":"Nagaraj","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0117","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1084\/jem.20131916","article-title":"PD-L1 is a novel direct target of HIF-1\u03b1, and its blockade under hypoxia enhanced MDSC-mediated T cell activation","volume":"211","author":"Noman","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0118","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1247135","article-title":"The expression profiles and regulation of PD-L1 in tumor-induced myeloid-derived suppressor cells","volume":"5","author":"Lu","year":"2016","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0119","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti\u2013PD-L1 antibody in patients with advanced cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0120","first-page":"4180","article-title":"Chronic lymphocytic leukemia-derived IL-10 suppresses antitumor immunity","volume":"200","author":"Alhakeem","year":"2018","journal-title":"JI"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0121","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12864-015-2359-6","article-title":"IL-10 and integrin signaling pathways are associated with head and neck cancer progression","volume":"17","author":"Bornstein","year":"2016","journal-title":"BMC Genomics"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0122","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2172-2-8","article-title":"Role of CD28\/B7 costimulation and IL-12\/IL-10 interaction in the radiation-induced immune changes","volume":"2","author":"Liu","year":"2001","journal-title":"BMC Immunol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0123","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.ijrobp.2021.03.022","article-title":"Low doses of radiation increase the immunosuppressive profile of lung macrophages during viral infection and pneumonia","volume":"110","author":"Meziani","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0124","doi-asserted-by":"crossref","first-page":"27158","DOI":"10.1074\/jbc.M115.682708","article-title":"Interleukin 10 (IL-10)-mediated immunosuppression","volume":"290","author":"Mittal","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0125","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.1365-2567.2002.01529.x","article-title":"Both exogenous and endogenous interleukin-10 affects the maturation of bone-marrow-derived dendritic cells in vitro and strongly influences T-cell priming in vivo","volume":"107","author":"Haase","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0126","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.4049\/jimmunol.147.11.3815","article-title":"IL-10 inhibits cytokine production by activated macrophages","volume":"147","author":"Fiorentino","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0127","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/thx.51.2.143","article-title":"Interleukin 10 (IL-10) regulation of tumour necrosis factor alpha (TNF-alpha) from human alveolar macrophages and peripheral blood monocytes","volume":"51","author":"Armstrong","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0128","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1016\/j.celrep.2018.11.050","article-title":"Myeloid-derived suppressor cells produce IL-10 to elicit DNMT3b-dependent IRF8 silencing to promote colitis-associated colon tumorigenesis","volume":"25","author":"Ibrahim","year":"2018","journal-title":"Cell Reports"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0129","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.immuni.2007.06.009","article-title":"The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8","volume":"27","author":"Tailor","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/ng1001-117","article-title":"TGF-\u03b2 signaling in tumor suppression and cancer progression","volume":"29","author":"Derynck","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0131","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1126\/science.8475385","article-title":"Negative regulation of G1 in mammalian cells: Inhibition of cyclin e-dependent kinase by TGF-\u03b2","volume":"260","author":"Koff","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0132","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1073\/pnas.92.12.5545","article-title":"Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism","volume":"92","author":"Datto","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0133","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0360-3016(00)00435-1","article-title":"TGF-\u03b21 and radiation fibrosis: A master switch and a specific therapeutic target?","volume":"47","author":"Martin","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0134","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1634\/theoncologist.2009-S101","article-title":"Targeting the TGF-\u03b21 pathway to prevent normal tissue injury after cancer therapy","volume":"15","author":"Anscher","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0135","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/dvdy.339","article-title":"Transforming growth factor-beta1 and myeloid-derived suppressor cells: A cancerous partnership","volume":"251","author":"Mojsilovic","year":"2022","journal-title":"Dev Dynam"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1876401001706010001","article-title":"Transforming growth factor-beta1 and myeloid-derived suppressor cells interplay in cancer","volume":"6","author":"Santibanez","year":"2017","journal-title":"TOCIJ"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0137","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/icb.2017.4","article-title":"Myeloid-derived suppressor cells can be efficiently generated from human hematopoietic progenitors and peripheral blood monocytes","volume":"95","author":"Casacuberta-Serra","year":"2017","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0138","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1002\/ijc.24249","article-title":"Induction of myeloid-derived suppressor cells by tumor exosomes","volume":"124","author":"Xiang","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0139","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1158\/2326-6066.CIR-18-0310","article-title":"Autocrine TGF\u03b2 is a survival factor for monocytes and drives immunosuppressive lineage commitment","volume":"7","author":"Gonzalez-Junca","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0140","first-page":"5500","article-title":"MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN","volume":"188","author":"Liu","year":"2012","journal-title":"JI"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0141","first-page":"1034","article-title":"MicroRNA-155 and MicroRNA-21 promote the expansion of functional myeloid-derived suppressor cells","volume":"192","author":"Li","year":"2014","journal-title":"JI"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0142","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fonc.2019.00156","article-title":"Novel approaches to improve the efficacy of immuno-radiotherapy","volume":"9","author":"Shevtsov","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0143","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1158\/2326-6066.CIR-20-0111","article-title":"Lactate-modulated immunosuppression of myeloid-derived suppressor cells contributes to the radioresistance of pancreatic cancer","volume":"8","author":"Yang","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0144","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/jnci\/djz036","article-title":"STAT3 modulation of regulatory T cells in response to radiation therapy in head and neck cancer","volume":"111","author":"Oweida","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0145","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.bbrc.2020.04.137","article-title":"LXR activation radiosensitizes non-small cell lung cancer by restricting myeloid-derived suppressor cells","volume":"528","author":"Liang","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0146","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1158\/1078-0432.CCR-14-2742","article-title":"Myeloid-derived suppressor cells as an immune parameter in patients with concurrent sunitinib and stereotactic body radiotherapy","volume":"21","author":"Chen","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0147","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00262-016-1941-3","article-title":"Immune modulation associated with vascular endothelial growth factor (VEGF) blockade in patients with glioblastoma","volume":"66","author":"Thomas","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0148","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2217\/imt.12.3","article-title":"Cellular immunotherapy for soft tissue sarcomas","volume":"4","author":"Finkelstein","year":"2012","journal-title":"Immunotherapy"},{"key":"10.1016\/j.ijrobp.2023.11.050_bib0149","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.633205","article-title":"Natural killer cell interactions with myeloid derived suppressor cells in the tumor microenvironment and implications for cancer immunotherapy","volume":"12","author":"Zalfa","year":"2021","journal-title":"Front Immunol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623081749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623081749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T21:08:13Z","timestamp":1729112893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301623081749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":149,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0360301623081749"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.11.050","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation Therapy and Myeloid-Derived Suppressor Cells: Breaking Down Their Cancerous Partnership","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.11.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}